Viola et al.,(18) corroborated these observations and showed that monocyte-derived exosomes from patient stroma protect the AML cell line against chemotherapy treatment with cytarabine or FLT3 inhibitor.(18). This evidence concerns the gene FLT3 and acute myeloid leukemia.